Journal of Internal MedicineVolume 229, Issue 2 p. 113-116 Free Access Fifty years of progress with antithrombotic drugs—with much more to come: a perspective* S. SHERRY MD., DSc, Corresponding Author S. SHERRY MD., DSc Department of Internal Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USADepartment of Internal Medicine, Temple University School of Medicine, 3400 N. Broad Street, Philadelphia, PA 19140, USA.Search for more papers by this author S. SHERRY MD., DSc, Corresponding Author S. SHERRY MD., DSc Department of Internal Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USADepartment of Internal Medicine, Temple University School of Medicine, 3400 N. Broad Street, Philadelphia, PA 19140, USA.Search for more papers by this author First published: February 1991 https://doi.org/10.1111/j.1365-2796.1991.tb00317.xCitations: 5 * Based on a presentation at the 40th Anniversary Celebration of the Swedish Society of Cardiology. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 McLean J. The thromboplastic action of cephalin. Am J Physiol 1916; 41: 250. 2 Jorpes JE. The chemistry of heparin. Biochem J 1935; 29: 1817– 30. 3 Crafoord C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir Scand 1937; 79: 407– 26. 4 Murray DWG, Jaques LB, Perrett TS, Best CH. Heparin and the thrombosis of veins following injury. Surgery 1937; 2: 163– 87. 5 Brinkhous KM, Smith HP, Warner ED, Seegers WH. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin to thrombin. Am J Physiol 1939; 125: 683– 7. 6 Link KP. The anticoagulant from spoiled sweet clover hay. Harvey Lecture Series. 194344; 34: 162– 216. 7 O'Brien JR. Effects of salicylates on human platelets. Lancet 1968; 1: 779– 83. 8 Zucker MB, Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med 1968; 127: 547– 51. 9 Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58: 485– 502. 10 Bizzozero J. Über einen neuen formbeständtheil des bluts und dessen rolle bei der thrombose und der blutgerinnung. Virchows Arch [A] 1882; 90: 261– 332. 11 Eberth JC, Schimmelbusch C. Experimentelle untersuchungen über thrombose. Virchows Arch [A] 1886; 103: 39– 87, 105: 331-50. 12 Welch WH. Thrombosis and embolism. In: TC Allbutt, ed. A System of Medicine. London: Macmillan, 1899; 155– 285. 13 Chandler AB. The anatomy of a thrombus. In: S. Sherry, KM Brinkhous, E. Genton, JM Stengle, eds. Thrombosis. Washington DC: National Academy of Sciences, 1969; 279– 99. 14 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927– 9. Citing Literature Volume229, Issue2February 1991Pages 113-116 ReferencesRelatedInformation